Deczuba 50 mg Injection
41,93$
36,26$
Deczuba 50 mg injection is a specialized anti-cancer treatment designed to address myelodysplastic syndromes, a condition where the bone marrow fails to produce sufficient healthy blood cells and instead generates excessive immature cells known as blasts. By targeting the underlying mechanisms of this disorder, Deczuba helps restore normal blood cell production, improving overall blood health and functionality. It is important to be aware of potential side effects, which may include low blood cell counts that can increase the risk of infections, bleeding, or anemia, necessitating regular monitoring during treatment. Patients receiving Deczuba should be cautious about any pre-existing health conditions and consult their healthcare provider regarding any concurrent medications. This injection is typically administered in a clinical setting under the supervision of a qualified healthcare professional. Deczuba represents a vital option for those battling the challenges posed by myelodysplastic syndromes, offering hope for improved health outcomes. Always discuss your treatment plan with your healthcare provider to ensure that Deczuba is appropriate for your individual needs.
Cantidad
Active Pharmaceutical Ingredient
Uses
• Deczuba 50 mg injection is primarily utilized in the treatment of myelodysplastic syndrome (MDS). This condition involves the production of abnormal blood cells in the bone marrow, which can lead to a significant decrease in healthy blood cells. Patients may experience symptoms such as fatigue, weakness, and easy bruising. By addressing the underlying issues associated with MDS, Deczuba helps improve blood cell production and overall patient well-being.
• Another important use of Deczuba 50 mg injection is in the management of acute myeloid leukemia (AML). This type of blood cancer affects the myeloid cells, which are crucial for producing various blood components. Patients with AML may suffer from severe fatigue, frequent infections, and easy bruising, among other symptoms. Deczuba works by targeting the cancerous cells, thereby aiding in the restoration of healthier blood cell function.
• Deczuba 50 mg injection can also be indicated for patients who have not responded to other treatments for MDS or AML. In such cases, it provides a valuable alternative therapeutic option. The medication helps to enhance the quality of life for these patients by mitigating symptoms and promoting better blood health. This effectiveness makes Deczuba a critical component in the treatment regimen for those facing these challenging conditions.
• In clinical settings, Deczuba 50 mg injection is often used as part of a broader treatment strategy for blood disorders. It may be administered in conjunction with other therapies to optimize patient outcomes. By incorporating Deczuba, healthcare providers aim to improve not just the blood cell counts but also the overall health and vitality of patients. This multifaceted approach helps address the complexities associated with myelodysplastic syndromes and acute myeloid leukemia.
Benefits
Myelodysplastic syndrome: Deczuba 50 mg Injection is used to treat myelodysplastic syndrome, a group of conditions in which the bone marrow produces blood cells that are abnormal in structure and function and does not produce enough healthy blood cells. Deczuba Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Acute myeloid leukemia (AML): Anti-cancer Drug Deczuba is used to treat acute myeloid leukemia, a type of blood cancer that affects the white blood cells, specifically, the myeloid cells, which are responsible for producing red blood cells, platelets, and other white blood cells. In AML, the myeloid cells become abnormal and do not function properly, leading to a decrease in healthy blood cells and an increase in abnormal cells. Decitabine Injection 50 mg kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells.
Side Effects
Most adverse effects do not require medical attention and will go away when your body gets used to the medicine. Inform your doctor if any of these symptoms get severe or that bother you for a longer period.
Most Common Side Effects
• Insomnia
• Nausea
• Constipation
• Diarrhoea
• Vomiting
• Stomach pain
• Painful sores in mouth or tongue or lips
• Indigestion
• Heartburn
• Rashes
• Itching
• Hair loss
• Skin discolouration
• Chest discomfort
• Muscle pain
• Joint pain
• Swelling over extremities
• Pain or swelling or redness over the injection site
• Weakness
• Confusion
• Headache
• Dizziness
• Extreme weakness
Common Side Effects
• Bruising
• Unusual bleeding
• Facial swelling
• Respiratory distress, breathing difficulty, rapid breathing, tachypnoea
• Sore throat
• High
• grade fever with chills
• Other signs of infection
How To Use
Deczuba 50 mg Injection is available in powder form, which must be diluted and administered into the vein (IV) slowly as directed by your doctor. Decitabine Injection 50 mg is administered by a doctor or nurse at a hospital or clinical setting. The dosage, frequency, and interval (duration of infusion) depend upon your medical condition, body size, lab test results, and response towards the treatment given. Don't administer this drug by yourself; it must be administered under medical supervision by healthcare professionals only. It may take several weeks or months for you to see or feel the benefits, but do not stop taking it unless your doctor tells you to. You should avoid drinking alcohol, as it may increase your risk of liver damage. Do not self-administer this Deczuba 50 mg.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Deczuba 50 mg. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Deczuba 50 mg Injection is safe for use in patients with mild to moderate kidney disease, no dose adjustment of Deczuba 50 mg Injection is recommended. The use of Deczuba 50 mg Tablet is not recommended for severe kidney disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Breastfeeding: It is not recommended to breastfeed while taking Deczuba 50 mg. Deczuba 50 mg Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Deczuba 50 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Deczuba 50 mg Injection is recommended for use in patients with mild to moderate liver disease. No dose adjustment is needed in such types of patients. In case patients suffer from severe liver disease, the use of this medicine in such types of people is not recommended, It may worsen the patient's condition.
• Pregnancy: Use of Deczuba 50 mg Injection may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Deczuba 50 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Deczuba 50 mg Injection may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Deczuba 50 mg.